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Abstract
Background
Cerebral microbleeds (CMB) occur in the context of cerebral small vessel disease. Other
brain MRI markers of cerebral small vessel disease are associated with the occurrence of
postoperative delirium (POD) and postoperative cognitive dysfunction (POCD), but for CMB
this is unknown. We aimed to study the association between CMB and the occurrence of
POD and POCD in older individuals.
Methods
The current study consists of 65 patients (72±5 years) from the BIOCOG study, which is a
prospective, observational study of patients who underwent an elective surgery of at least
60 minutes. Patients in the current study received a preoperative cerebral MRI scan includ-
ing a 3D susceptibility-weighted imaging sequence to detect CMB. The occurrence of POD
was screened for twice a day until postoperative day 7 by using the DSM-5, NuDesc, CAM,
and CAM-ICU. The occurrence of POCD was determined by the reliable change index
model at 7 days after surgery or discharge, respectively, and 3 months after surgery. Statis-
tical analyses consisted of logistic regression adjusted for age and gender.
Results
A total of 39 CMB were detected in 17 patients (26%) prior to surgery. POD occurred in 14
out of 65 patients (22%). POCD at 7 days after surgery occurred in 11 out of 54 patients
(20%) and in 3 out of 40 patients at the 3 month follow-up (8%). Preoperative CMB were not
associated with the occurrence of POD (OR (95%-CI): 0.28 (0.05, 1.57); p = 0.147) or
POCD at 7 days after surgery (0.76 (0.16, 3.54); p = 0.727) or at 3 months follow-up (0.61
(0.03, 11.64); p = 0.740).
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Conclusion
We did not find an association between preoperative CMB and the occurrence of POD or
POCD.
Trial registration
clinicaltrials.gov (NCT02265263) on 23 September 2014.
Introduction
Postoperative delirium (POD) and postoperative cognitive dysfunction (POCD) occur com-
monly, particularly in older patients who have multimorbidity. Delirium in general is an acute
condition characterized by a deterioration of attention, cognition and awareness that cannot
be fully accounted for by a pre-existing neuropsychiatric disease. It might be associated with
disturbances of arousal, sleep-wake cycle and affection [1]. Occurrence of POD is associated
with a poor outcome and an increased risk of POCD [2, 3]. POCD consists of impairments in
memory and executive functioning after surgery that tend to persist over time [4]. POD and
POCD have a large incidence (POD (15–53%); POCD (10–54%)) and are currently clinically
more recognized due to an increased awareness [5, 6]. Both POD and POCD are associated
with a reduced quality of life, longer hospital stay, increased mortality and higher healthcare
costs [7].
The exact underlying pathophysiological mechanisms of POD and POCD are still unclear,
but certain structural brain changes on magnetic resonance imaging (MRI) are associated with
an increased risk [8]. For instance, MRI markers of cerebral small vessel disease like white mat-
ter hyperintensities (WMH) are associated with the occurrence of POD and POCD [8]. How-
ever, for other MRI markers of cerebral small vessel disease, especially cerebral microbleeds
(CMB), this is still unknown [8]. CMB occur in the context of aging and in cerebral small ves-
sel disease and they are associated with an increased risk of cognitive decline and dementia [9].
We therefore aimed to study the association between CMB and the occurrence of POD and
POCD in older patients.
Material and methods
Study participants
The Biomarker Development for Postoperative Cognitive Impairment in the Elderly (BIO-
COG) study is a large prospective multicenter observational study, which aims to establish
valid biomarkers for risk analysis and clinical outcome prediction of POD and POCD in a
sample of elderly (�65 years) patients presenting for major elective surgery (>60 min dura-
tion) at the Charite´—Universita¨tsmedizin Berlin, Germany [10]. Further inclusion criteria
were European descent, the ability to give informed consent and to undergo neuropsychologi-
cal testing, and eligibility for MRI. Patients were excluded when the Mini-Mental-State-Exami-
nation was�23 points, when homeless or the patient would not be reachable for follow-up,
when participating in another prospective interventional clinical study during hospital stay,
when accommodated in an institution due to an official or judicial order, in case of neuropsy-
chiatric morbidity, anacusis or hypoacusis, intake of centrally acting medication or any other
condition which could interfere with neurocognitive testing. Overall, 1033 patients were
included into the BIOCOG study. Within the BIOCOG study, our substudy was performed
consisting of 66 patients who received a 3D susceptibility-weighted imaging (3D SWI)
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sequence in their preoperative MRI scan. Our substudy was performed in consecutive
included patients between April 2016 and October 2017. One patient was excluded due to
missing primary endpoints of the BIOCOG study, leaving 65 patients for our current study.
The study was approved by our medical ethics committee (Ethikkommission der Charite´–
Universita¨tsmedizin Berlin, EA2/092/14) and all patients signed an informed consent form.
This clinical trial meets the requirements set out by the ICH-GCP and Declaration of Helsinki.
Clinical data
Baseline patients demographics (age, gender, body mass index (BMI), American Society of
Anesthesiologists (ASA) score, Mini-Mental State Examination (MMSE)) and cardiovascular
risk factors (hypertension, diabetes, hypercholesterolemia, history of stroke, coronary and
chronic heart disease) were obtained at the day of inclusion at a pre-surgery interview and by
viewing the medical records. Medical history data were collected by either study physicians
(anesthesiologist or anesthesiologist in training) or additional trained research staff (study
nurses, psychology or MD students) under supervision of a physician. Clinical history and
long-term medication data were assessed in a structured interview. Medical records were
reviewed for additional data whenever a patient had presented in the clinic before. Whenever
possible, records of medical findings and physician’s letters were obtained from the patients
and screened for additional data. Post-hoc, all clinical data have been reviewed and were vali-
dated by a study physician (anesthesiologist).
All patients received a preoperative neurocognitive assessment by trained medical staff
which consisted of a CANTAB battery [11] (Paired Associates Learning, Verbal Recognition
Memory, Simple Reaction Time, Spatial Span Time) as well as Trail Making Tests and
Grooved Pegboard.
Peri- and postoperative parameters (surgical time, type of surgery, postoperative complica-
tions, intensive care unit (ICU) and in-patient duration, in-patient deaths) were documented
by trained medical staff.
POD and POCD
Detection of POD was conducted by screening of the patients twice a day until postoperative
day 7 or discharge using the 5th edition of the Diagnostic and Statistical Manual of Mental Dis-
orders (DSM-5) [1], NuDesc [12], CAM [13], and CAM-ICU [14]. POD is defined according
to DSM-5 criteria. Patients were considered delirious in case of� 2 cumulative points on the
NuDesc and/or positive CAM score and/or positive CAM-ICU score and/or patient chart
review that shows description of delirium (e.g., confused, agitated, drowsy, disorientated,
delirious, received antipsychotic therapy).
At postoperative day 7 or discharge, respectively, as well as three months after surgery,
patients received a follow-up neurocognitive assessment to detect POCD (Fig 1), which was cal-
culated for the whole BIOCOG cohort by the reliable change index model as published by Ras-
mussen et al. [15]. This method corrects for learning effects and natural variability in repetitive
cognitive testing by use of data from the BIOCOG non-surgical control group (n = 114), that
also served to provide normative data. We imputed missing data according to random forest
(technical, organizational or physiological problems) or worst case imputation paradigm (signs
of cognitive impairment) whenever parts of the cognitive testing were not performed [16].
MRI scans
MRI scans were performed at the Berlin Institute for Advance Neuroimaging (BCAN), Ger-
many. Scans were acquired in one TIM Trio 3T MRI (Siemens, Erlangen, Germany) with a
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32-channel head coil. All patients received a preoperative brain MRI scan with a standardized
scan protocol including a 3D susceptibility weighted gradient echo MRI sequence (SWI, voxel
size: 0.7×0.6×1.2 mm; field of view: 230×180 mm in 120 transversal slices; TE: 20 ms; TR: 28
ms, 15˚ flip angle) to detect CMB, a fluid-attenuated inversion recovery (FLAIR) sequence
(TR/TE/inversion time = 4800/388/1800 ms; voxel size = 0.49x0.49x1.00mm3) and a 3D T1
magnetization-prepared rapid acquisition gradient echo sequence (TR/TE = 2500 / 4.77 ms;
voxel size = 1.00 x 1.00 x 1.00 mm3) to detect presence of lacunar infarcts and WMH. Addi-
tionally, patients had a follow-up MRI scan 3 months after surgery with an identical scan
protocol.
MRI processing steps
CMB and presence of lacunar infarcts were determined by a (neuro-)radiologist (JB) who was
blinded to patient outcomes. CMB were further categorized as lobar or deep CMB according
to the Microbleed Anatomical Rating Scale [17]. Presence of lacunar infarcts was determined
according to the STRIVE criteria [18]. WMH volume was determined by an automated
method: the lesion prediction algorithm [19] of the lesion segmentation toolbox (LST) version
2.0.15 (www.statistical-modeling.de/lst.html), for statistical parametric mapping software
(SPM12, Wellcome Institute of Neurology, University College London, UK, http://www.fil.
ion.ucl.ac.uk/spm/doc/), running on Matlab version R2016b. If present, cortical infarcts were
manually segmented and subtracted from the WMH probability maps before calculating the
WMH volume. All WMH probability maps were checked for accurate segmentation by a
trained researcher (IK).
Statistical analysis
Results for normally distributed data are presented as arithmetic mean ± standard deviation
(SD) and for non-normal distributed data as median with quartiles. Categorical data are sum-
marized as frequencies in %. Differences in baseline patient demographics were assessed using
Fisher’s exact tests for category variables, and Mann-Whitney U tests for contiguous data.
Logistic regression models adjusted for age and sex were used to determine the odds ratio’s for
occurrence of POD and POCD in patients with versus without preoperative CMB. Similar
analyses were used for postoperative CMB patients. In exploratory analyses for POD and
POCD, we performed the logistic regression models separately for lobar and deep CMB. Odds
ratios (OR) are shown with 95%-confidence intervals (CI). A two-tailed p-value <0.05 was
considered statistically significant. All statistical analyses were performed with IBM SPSS Sta-
tistics, Version 25.
Fig 1. Time line of measurements.
https://doi.org/10.1371/journal.pone.0218411.g001
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Results
Study population
A total of 17 out of 65 patients (26%) had 39 CMB prior to surgery. Of these, 13 patients
showed only lobar CMB, 2 patients had only deep CMB and both types of CMB were seen in 2
patients (S1 Table). Baseline patient demographics, peri- and postoperative parameters and
cardiovascular risk factors did not differ between the patients with preoperative CMB versus
patients without preoperative CMB (Table 1). Types of surgery are shown in S2 Table. Two
patients received spinal anesthesia, all other patients were put under general anesthesia. Out of
the 65 included patients, all had POD screening, 54 (83%) had a follow-up neurocognitive
assessment for POCD at 7 days and 40 (62%) at 3 months after surgery. Results of the cognitive
tests at baseline and after three months are presented in the S1 Text. A total of 34 patients
(52%) received a follow-up brain MRI scan at 3 months. WMH volumes (p = 0.002) were sig-
nificantly higher in patients with CMB.
Table 1. Patient characteristics and peri- and postoperative parameters.
Total (n = 65) Patients without CMB (n = 48) Patients with CMB (n = 17) P value
Demographics
Age [years] 72.2 ± 5.2 71.7 ± 5.2 73.7 ± 5.0 0.162
Male gender 30 (46%) 23 (48%) 7 (41%) 0.779
Body Mass Index [kg/m2] 26.8 ± 3.9 26.9 ± 3.8 26.6 ± 4.3 0.314
ASA score 0.466
I 1 (2%) 0 1 (6%)
II 41 (63%) 33 (69%) 8 (47%)
III 22 (34%) 14 (29%) 8 (47%)
IV 0 0 0
V 1 (2%) 1 (2%) 0
Baseline MMSE 29 (28, 30) 29 (27, 30) 29 (28, 30) 0.760
Peri- and postoperative parameters
Surgical time [min] 105 (67, 208) 106 (71, 214) 104 (60, 173) 0.502
Intra-abdominal/-thoracic surgery 16 (25%) 13 (27%) 3 (18%) 0.528
ICU duration [days] 0 (0, 0) 0 (0, 0) 0 (0, 1) 0.724
In-patient duration [days] 7 (4, 9) 7 (4, 9) 6 (4, 10) 0.851
Deceased during hospital stay 2 (3%) 2 (4%) 0 1.000
Cardiovascular risk factors
Hypertension 41 (63%) 28 (58%) 13 (77%) 0.247
Stroke in history 6 (9%) 3 (6%) 3 (18%) 0.179
Diabetes 14 (22%) 11 (23%) 3 (18%) 0.745
Coronary and chronic heart disease 10 (15%) 6 (13%) 4 (24%) 0.434
Hypercholesterinemia 25 (39%) 15 (31%) 10 (59%) 0.080
MRI markers of cerebral small vessel disease
WMH volume [ml] 2.1 (0.7, 5.0)� 1.7 (0.5, 3.8)� 6.4 (1.4, 20.2) 0.002
Patients with lacunar infarcts 10 (15%) 5 (10%) 5 (29%) 0.111
Continuous variables in mean ± standard deviation (normal distributed data) and median (25%-75% percentiles (non-normal distributed data), frequencies with n (%);
ASA, American Society of Anesthesiologists; ICU, Intensive Care Unit; MMSE, Mini-Mental State Examination; WMH, white matter hyperintensities.
�one patient had to be excluded from analysis due to previous neurosurgery.
https://doi.org/10.1371/journal.pone.0218411.t001
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The association of preoperative CMB and occurrence of POD and POCD
POD occurred in 14 out of 65 patients (22%), POCD at 7 days after surgery in 11 out of 54
patients (20%) as well as in 3 out of 40 patients at the 3 month follow-up (8%). Preoperative
CMB were not associated with the occurrence of POD (OR (95%-CI): 0.28 (0.05, 1.57);
p = 0.147) or POCD at 7 days after surgery (0.76 (0.16, 3.54); p = 0.727) or at 3 months follow-
up (0.61 (0.03, 11.64); p = 0.740) (Table 2). In exploratory analysis considering lobar and deep
CMB separately, no associations were found with POD or POCD at 7 days or 3 months after
surgery.
Patients with preoperative CMB and new CMB after surgery
Of the 34 patients with follow-up MRI scans, 11 patients had preoperative CMB, whereas 4 of
these patients (36%) developed new CMB after surgery (S1 Table). No new CMB occurred
after surgery in patients without preoperative CMB. Postoperative presence of CMB was not
significantly associated with POD (1.15 (0.08, 17.43; p = 0.918) or POCD at 7 days (2.66 (0.26,
27.35); p = 0.412) or at 3 months (0.34 (0.01, 8.53); p = 0.512) after surgery.
Discussion
Our study showed that the presence of preoperative or postoperative CMB was not associated
with occurrence of POD or POCD in older individuals. Our study is the first to investigate this
association.
CMB are one of the MRI markers for cerebral small vessel disease [20]. Only few previous
studies have examined brain MRI markers of cerebral small vessel disease in relation to POD
or POCD, and to the best of our knowledge, no study has yet analyzed CMB in post-operative
cognitive disorders. A recent review summarized studies investigating associations between
POD/POCD and WMH/lacunar infarcts, which are other markers of cerebral small vessel dis-
ease [8]. They reported on six studies on the association between POD/POCD and WMH with
a total of 504 participants that yielded contradictory results [21–26]. Especially the largest
study with 146 participants did not report a significant association between WMH and POD
[27]. Previous studies with a total of 71 participants on preoperative WMH and POCD have
shown that WMH were related to POCD [23, 24]. No previous studies have assessed presence
of lacunar infarcts as a separate measure. These results have suggested that brain MRI markers
for cerebral small vessel disease might play a role in the underlying pathophysiological mecha-
nisms of POD and POCD.
Our findings show that neither preoperative nor (new) postoperative CMB were associated
with occurrence of POD or POCD. Preoperative CMB might therefore not play a role in the
Table 2. The association between preoperative CMB and occurrence of POD and POCD.
Patient without CMB (n = 48) Patients with CMB (n = 17) OR
(95% CI)
P value
POD 12 (25%) 2 (12%) 0.278
(0.049, 1.565)
0.147
POCD 7 days after surgery� 8 (21%) 3 (19%) 0.761
(0.164, 3.535)
0.727
POCD 3 months after surgery� 2 (7%) 1 (10%) 0.606
(0.032, 11.637)
0.740
�calculated for 54 patients with POCD assessment after 7 days and 40 patients with POCD assessment after 3 months. Frequencies with n (%); CI, confident interval;
OR, odds ratio; POD, postoperative delirium; POCD, postoperative cognitive dysfunction.
https://doi.org/10.1371/journal.pone.0218411.t002
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pathogenesis of POD or POCD. However, previous studies did show an association between
other brain MRI markers of cerebral small vessel disease and POD or POCD [8]. Possible
explanations for these discrepancies might be that other markers of cerebral small vessel dis-
ease are stronger preoperative predictors of POD and POCD risk. Other factors that might
have played a role are our limited sample size, reducing the power to detect an association, and
the relatively low prevalence of CMB in comparison to other markers for cerebral small vessel
disease, such as presence of WMH. The prevalence of CMB was 26% in our cohort, which is
somewhat higher compared to population based cohorts like the Rotterdam Study (19% [26])
and the Framingham Heart Study (8% [28]). However, it should be taken into account that
our patients were approximately one decade older than patients in the Rotterdam study and
Framingham study, while age constitutes a risk factor for CMB [29].
To the best of our knowledge, no previous studies have assessed the relation between CMB
progression and occurrence of POD or POCD. However, one previous study has assessed the
relation between progression of other markers of cerebral small vessel disease (WMH and
infarcts) and occurrence of POCD [25]. They have shown that progression of WMH and lacu-
nar infarcts after surgery was not related to postoperative cognitive status. Nevertheless, Patel
and colleagues investigated a sample of patients presenting for cardiac surgery. New infarcts
after cardiac surgery are thought to be of thrombembolic origin, although pre-operative ath-
erosclerotic burden has been suggested to increase the risk for new post-operative brain
infarcts [30]. On the other hand, intraoperative hypoperfusion is thought to cause periopera-
tive infarcts in patients with preexisting cerebral small vessel disease, which might be similar
for surgical procedures other than cardiac surgery [31]. Furthermore, we have found no new
CMB after surgery in patients without preoperative CMB, but 4 out of 11 patients with preop-
erative CMB developed new CMB after surgery. Within these patients, it is unknown whether
progression of CMB is related to progression of cerebral small vessel disease over time or is
related to the operation.
Strengths of our study are the pre- and postoperative performed brain MRI scans that
enabled us to systematically analyze pre- and postoperative CMB. Furthermore, the assessment
of POD was done twice daily after surgery, included multiple screening tools and a chart
review, which has increased our sensitivity to detect POD. We have assessed POCD according
to the latest guidelines as proposed by Rasmussen et al. [15]. A limitation of our study might
be the relatively small number of patients as our study was performed as a substudy. It may
further be population biased as only a relatively small number of patients of the overall BIO-
COG cohort were analyzed. This might reduce the power to detect an association between
CMB and occurrence of POD or POCD. However, there are no previously published studies
addressing the association between CMB and the occurrence of POD or POCD. Another limi-
tation might be the relatively low number of participants at the 3 month follow-up for the
assessment of POCD (62%) and for the brain MRI (52%). Also, the patients who were lost to
follow-up might have been suffering from a worse postoperative cognitive and physical status
compared to the patients that returned for follow-up. This could have resulted in some selec-
tion bias. Finally, one should consider that patients in our sample have rarely been admitted to
the ICU for more than 24 hours. Thus, overall post-operative physical stress in our sample was
probably low. This might reflect a relatively low incidence of postoperative triggers for cogni-
tive disorders in our study. The majority of patients in our study might have not developed
POD or POCD due to the lack of triggers. Taken together, these factors might have led to an
underestimation of the effect of CMB on occurrence of POD or POCD.
In conclusion, we did not find an association between preoperative CMB and the occur-
rence of POD or POCD.
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